Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 6 | 2024 | 111 | 3.770 |
Why?
|
| Glioma | 6 | 2023 | 79 | 3.270 |
Why?
|
| Glioblastoma | 4 | 2024 | 55 | 3.250 |
Why?
|
| Blood Platelets | 4 | 2020 | 77 | 2.470 |
Why?
|
| Focal Adhesion Kinase 2 | 4 | 2023 | 14 | 1.200 |
Why?
|
| Alzheimer Disease | 3 | 2020 | 905 | 1.200 |
Why?
|
| Thrombosis | 2 | 2018 | 63 | 1.150 |
Why?
|
| Mice, Inbred C57BL | 9 | 2023 | 1609 | 0.900 |
Why?
|
| Cytochromes c | 2 | 2019 | 53 | 0.820 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2019 | 95 | 0.800 |
Why?
|
| Astrocytes | 8 | 2019 | 255 | 0.790 |
Why?
|
| Amyloidosis | 1 | 2020 | 33 | 0.740 |
Why?
|
| Animals | 20 | 2023 | 15081 | 0.700 |
Why?
|
| Signal Transduction | 3 | 2024 | 1908 | 0.700 |
Why?
|
| Parkinson Disease | 1 | 2020 | 178 | 0.650 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 807 | 0.640 |
Why?
|
| Glaucoma | 1 | 2019 | 85 | 0.620 |
Why?
|
| Mice | 9 | 2023 | 5913 | 0.600 |
Why?
|
| Connexin 43 | 2 | 2017 | 38 | 0.600 |
Why?
|
| Gap Junctions | 2 | 2017 | 38 | 0.600 |
Why?
|
| Skin | 1 | 2018 | 174 | 0.580 |
Why?
|
| Peptide Fragments | 1 | 2019 | 308 | 0.580 |
Why?
|
| Brain | 3 | 2020 | 1346 | 0.580 |
Why?
|
| Polyamines | 1 | 2017 | 30 | 0.570 |
Why?
|
| Entorhinal Cortex | 1 | 2016 | 13 | 0.570 |
Why?
|
| Cerebrovascular Disorders | 1 | 2016 | 37 | 0.560 |
Why?
|
| Visual Cortex | 1 | 2016 | 60 | 0.560 |
Why?
|
| Cell Line, Tumor | 5 | 2023 | 2231 | 0.520 |
Why?
|
| Microglia | 1 | 2015 | 166 | 0.450 |
Why?
|
| Pyridinium Compounds | 1 | 2012 | 27 | 0.430 |
Why?
|
| Staining and Labeling | 1 | 2012 | 105 | 0.420 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 4 | 2015 | 61 | 0.380 |
Why?
|
| Humans | 14 | 2024 | 37093 | 0.350 |
Why?
|
| Neurons | 1 | 2017 | 1175 | 0.350 |
Why?
|
| Glutamic Acid | 3 | 2015 | 128 | 0.280 |
Why?
|
| Spermine | 2 | 2017 | 64 | 0.250 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2024 | 19 | 0.240 |
Why?
|
| Microscopy, Confocal | 2 | 2016 | 218 | 0.240 |
Why?
|
| Rats | 7 | 2017 | 3483 | 0.230 |
Why?
|
| Embryo Implantation | 1 | 2023 | 32 | 0.230 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 1371 | 0.230 |
Why?
|
| Potassium | 4 | 2015 | 112 | 0.210 |
Why?
|
| Membrane Potentials | 6 | 2015 | 223 | 0.210 |
Why?
|
| Cells, Cultured | 5 | 2019 | 1518 | 0.200 |
Why?
|
| Flow Cytometry | 1 | 2023 | 399 | 0.200 |
Why?
|
| Cell Survival | 1 | 2023 | 864 | 0.180 |
Why?
|
| Male | 4 | 2024 | 20025 | 0.180 |
Why?
|
| Cell Membrane | 3 | 2018 | 381 | 0.180 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2017 | 364 | 0.180 |
Why?
|
| Autoantibodies | 1 | 2020 | 103 | 0.170 |
Why?
|
| Puerto Rico | 1 | 2024 | 1378 | 0.170 |
Why?
|
| Folic Acid | 1 | 2019 | 46 | 0.170 |
Why?
|
| Dermis | 1 | 2018 | 8 | 0.160 |
Why?
|
| Hypercalcemia | 1 | 2017 | 13 | 0.150 |
Why?
|
| Female | 4 | 2024 | 20969 | 0.150 |
Why?
|
| Platelet Count | 1 | 2016 | 13 | 0.150 |
Why?
|
| Thrombocytopenia | 1 | 2016 | 21 | 0.140 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 206 | 0.140 |
Why?
|
| Acidosis | 1 | 2017 | 51 | 0.140 |
Why?
|
| Microscopy, Electron | 1 | 2016 | 209 | 0.140 |
Why?
|
| Photic Stimulation | 1 | 2016 | 115 | 0.140 |
Why?
|
| Sweetening Agents | 1 | 2015 | 12 | 0.130 |
Why?
|
| Up-Regulation | 2 | 2015 | 513 | 0.130 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2015 | 14 | 0.130 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 20 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 173 | 0.120 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 133 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 893 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 251 | 0.120 |
Why?
|
| Calcium | 1 | 2017 | 480 | 0.120 |
Why?
|
| Glucose | 1 | 2015 | 230 | 0.120 |
Why?
|
| Seizures | 2 | 2010 | 68 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 617 | 0.110 |
Why?
|
| Spermidine | 1 | 2012 | 33 | 0.110 |
Why?
|
| Cation Transport Proteins | 1 | 2012 | 34 | 0.110 |
Why?
|
| Aged | 1 | 2024 | 6741 | 0.100 |
Why?
|
| Cell Communication | 1 | 2012 | 97 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 252 | 0.100 |
Why?
|
| Nanoparticles | 1 | 2016 | 318 | 0.100 |
Why?
|
| Cell Movement | 1 | 2015 | 571 | 0.100 |
Why?
|
| Patch-Clamp Techniques | 4 | 2015 | 223 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 36 | 0.090 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2010 | 12 | 0.090 |
Why?
|
| Ion Channel Gating | 1 | 2010 | 83 | 0.090 |
Why?
|
| Potassium Channels | 1 | 2010 | 75 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1015 | 0.090 |
Why?
|
| Quinolines | 1 | 2010 | 64 | 0.090 |
Why?
|
| Middle Aged | 1 | 2024 | 10129 | 0.090 |
Why?
|
| Adult | 1 | 2024 | 11712 | 0.080 |
Why?
|
| Mutation | 1 | 2010 | 1095 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 290 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2007 | 435 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2015 | 343 | 0.050 |
Why?
|
| Barium | 2 | 2010 | 17 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2015 | 1618 | 0.040 |
Why?
|
| Micelles | 1 | 2016 | 32 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 61 | 0.030 |
Why?
|
| Neocortex | 1 | 2015 | 27 | 0.030 |
Why?
|
| Colorimetry | 1 | 2015 | 40 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2016 | 125 | 0.030 |
Why?
|
| Polymers | 1 | 2016 | 121 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2015 | 70 | 0.030 |
Why?
|
| Hela Cells | 1 | 2016 | 366 | 0.030 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2015 | 77 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 202 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 550 | 0.030 |
Why?
|
| Giant Cells | 1 | 2012 | 13 | 0.030 |
Why?
|
| Intracellular Fluid | 1 | 2012 | 26 | 0.030 |
Why?
|
| Carbenoxolone | 1 | 2012 | 10 | 0.030 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2012 | 34 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2012 | 45 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1039 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2012 | 181 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1207 | 0.020 |
Why?
|
| Channelopathies | 1 | 2010 | 5 | 0.020 |
Why?
|
| Ataxia | 1 | 2010 | 9 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2010 | 8 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1742 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 74 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 71 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 132 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2010 | 269 | 0.020 |
Why?
|
| Fluorescence | 1 | 2010 | 121 | 0.020 |
Why?
|
| Neuroglia | 1 | 2010 | 124 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 103 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 408 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 523 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1398 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 1180 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 1568 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2007 | 33 | 0.020 |
Why?
|
| Hippocampus | 1 | 2010 | 561 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 628 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2010 | 808 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1354 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 767 | 0.020 |
Why?
|
| RNA Interference | 1 | 2007 | 243 | 0.020 |
Why?
|
| Homeostasis | 1 | 2007 | 188 | 0.020 |
Why?
|